Trading involves risk
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Trading involves risk
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
English (International)
Fortrea Holdings Inc.
Closed
SectorHealthcare
6.39 -2.89
Overview
Share price change
24h
Min
6.05
Max
6.79
Income | -502M -563M |
|---|---|
Sales | -46M 651M |
Profit margin | -86.427 |
Employees | 15,000 |
EBITDA | -474M -506M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | -1.52% downside |
Next Earnings | 7 Nov 2025 |
|---|
Market Cap | 14M 581M |
|---|---|
Previous open | 9.28 |
Previous close | 6.39 |
News Sentiment
By Acuity
50%
50%
162 / 374 Healthcare
Fortrea Holdings Inc. Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Fortrea Holdings Inc. Forecast
Price Target
By TipRanks
-1.52% downside
12 Months Forecast
Average 6.48 USD -1.52%
High 9 USD
Low 4.75 USD
Based on 11 Wall Street analysts offering 12 month price targets forFortrea Holdings Inc. - Dist in the last 3 months.
Sentiment
By Acuity
162 / 374 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Fortrea Holdings Inc.
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
